Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM2B | Q8NHM5 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.32 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10021864 | 0.93 | ALDH1A1 (0.33) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL10021859 | 0.83 | MEN1 (0.32) | KDM2BALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL472300 | 0.82 | CYP2D6 (0.33) | KDM2BALDH1A1KMT2AMEN1CYP2D6 | |
| SCHEMBL10021858 | 0.81 | ALDH1A1 (0.38) | ALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL10021856 | 0.81 | CYP2D6 (0.32) | ALDH1A1KMT2AMEN1CYP2D6 | |
| SCHEMBL17936648 | 0.81 | ALDH1A1 (0.44) | ALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL10021861 | 0.80 | ALDH1A1 (0.32) | KDM2BALDH1A1KMT2AMEN1CYP2D6 | |
| SCHEMBL10021857 | 0.80 | ALDH1A1 (0.32) | KDM2BALDH1A1KMT2AMEN1CYP2D6 | |
| SCHEMBL10021860 | 0.79 | MEN1 (0.36) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL471779 | 0.79 | SMN1; SMN2 (0.38) | ALDH1A1KMT2AMEN1L3MBTL1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2413192-B1 | POLYMERIZABLE MONOMERS | SHINETSU CHEMICAL CO (JP) | 2016-12-21 | — | — | EP | disclosed |
| US-8501942-B2 | Polymerizable monomers | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-08-06 | — | — | US | disclosed |
| US-8501942-B2 | Polymerizable monomers | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-08-06 | — | — | US | disclosed |
| US-20120029193-A1 | POLYMERIZABLE MONOMERS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120029193-A1 | POLYMERIZABLE MONOMERS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2413192-A1 | Polymerizable monomers | Shin-Etsu Chemical Co., Ltd. (JP) | 2012-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029193-A1 | POLYMERIZABLE MONOMERS | C9, CCNA1, H1-0 | KDM2B 3167/4885ALDH1A1 619/4885KMT2A 2389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.